Changing careers: Skin pathogen evolves to infect the bloodstream

Cell Host Microbe. 2023 Feb 8;31(2):166-167. doi: 10.1016/j.chom.2023.01.005.

Abstract

Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) rose to clinical dominance decades ago and predominantly manifested as skin and soft-tissue infections (SSTIs). These clones were distinct from those causing hospital acquired (HA-MRSA) infections. Dyzenhaus et al. describe the evolutionary changes necessary for CA-MRSA clones to cause bloodstream infections (BSIs).

Publication types

  • Comment

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Community-Acquired Infections* / drug therapy
  • Humans
  • Methicillin-Resistant Staphylococcus aureus* / genetics
  • Skin
  • Soft Tissue Infections* / drug therapy
  • Staphylococcal Infections* / drug therapy
  • Staphylococcal Skin Infections* / drug therapy

Substances

  • Anti-Bacterial Agents